163 related articles for article (PubMed ID: 34172737)
1. Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma.
Dong J; Li J; Li Y; Ma Z; Yu Y; Wang CY
Nat Commun; 2021 Jun; 12(1):3974. PubMed ID: 34172737
[TBL] [Abstract][Full Text] [Related]
2. Targeting BMI1
Chen D; Wu M; Li Y; Chang I; Yuan Q; Ekimyan-Salvo M; Deng P; Yu B; Yu Y; Dong J; Szymanski JM; Ramadoss S; Li J; Wang CY
Cell Stem Cell; 2017 May; 20(5):621-634.e6. PubMed ID: 28285905
[TBL] [Abstract][Full Text] [Related]
3. METTL3-mediated ALDH m
Chen Z; Chen J; Xu X; Li Q; Zhang C; Li S; Liu L; Cao C; Chen D; He Q
Oral Dis; 2024 Apr; 30(3):1061-1071. PubMed ID: 37249063
[TBL] [Abstract][Full Text] [Related]
4. CYTOR Facilitates Formation of FOSL1 Phase Separation and Super Enhancers to Drive Metastasis of Tumor Budding Cells in Head and Neck Squamous Cell Carcinoma.
Wang W; Yun B; Hoyle RG; Ma Z; Zaman SU; Xiong G; Yi C; Xie N; Zhang M; Liu X; Bandyopadhyay D; Li J; Wang C
Adv Sci (Weinh); 2024 Jan; 11(4):e2305002. PubMed ID: 38032139
[TBL] [Abstract][Full Text] [Related]
5. Generation of a squamous cell carcinoma mouse model for lineage tracing of BMI1+ cancer stem cells.
Chen D; Zhang W; Jia L; Wang C; Wang CY
STAR Protoc; 2021 Jun; 2(2):100484. PubMed ID: 33982017
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma.
Liu S; Qin Z; Mao Y; Wang N; Zhang W; Wang Y; Chen Y; Jia L; Peng X
Theranostics; 2024; 14(2):622-639. PubMed ID: 38169606
[No Abstract] [Full Text] [Related]
7. Melatonin inhibits the stemness of head and neck squamous cell carcinoma by modulating HA synthesis via the FOSL1/HAS3 axis.
Luo X; Wang J; Chen Y; Zhou X; Shao Z; Liu K; Shang Z
J Pineal Res; 2024 Mar; 76(2):e12940. PubMed ID: 38402581
[TBL] [Abstract][Full Text] [Related]
8. Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review).
Yongprayoon V; Wattanakul N; Khomate W; Apithanangsiri N; Kasitipradit T; Nantajit D; Tavassoli M
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38606512
[TBL] [Abstract][Full Text] [Related]
9. The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression.
Su W; Han HH; Wang Y; Zhang B; Zhou B; Cheng Y; Rumandla A; Gurrapu S; Chakraborty G; Su J; Yang G; Liang X; Wang G; Rosen N; Scher HI; Ouerfelli O; Giancotti FG
Cancer Cell; 2019 Aug; 36(2):139-155.e10. PubMed ID: 31327655
[TBL] [Abstract][Full Text] [Related]
10. BET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma.
Zhang M; Wang G; Ma Z; Xiong G; Wang W; Huang Z; Wan Y; Xu X; Hoyle RG; Yi C; Hou J; Liu X; Chen D; Li J; Wang C
Mol Ther; 2022 Nov; 30(11):3394-3413. PubMed ID: 35923111
[TBL] [Abstract][Full Text] [Related]
11. Immune Suppression Mediated by STAT4 Deficiency Promotes Lymphatic Metastasis in HNSCC.
Anderson K; Ryan N; Volpedo G; Varikuti S; Satoskar AR; Oghumu S
Front Immunol; 2019; 10():3095. PubMed ID: 32010142
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic Imidazolyl-Mesalazine Ester-Based Ru(II) Complexes Reduce Expression of Stemness Genes and Induce Differentiation of Oral Squamous Cell Carcinoma.
Kumari P; Ghosh S; Acharya S; Mitra P; Roy S; Ghosh S; Maji M; Singh S; Mukherjee A
J Med Chem; 2023 Oct; 66(20):14061-14079. PubMed ID: 37831489
[TBL] [Abstract][Full Text] [Related]
13. The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling.
Sharma D; Hager CG; Shang L; Tran L; Zhu Y; Ma A; Magnuson B; Lesko MW; Wicha MS; Burness ML
Breast Cancer Res; 2023 Nov; 25(1):144. PubMed ID: 37968653
[TBL] [Abstract][Full Text] [Related]
14. PROTAC Prodrug-Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer.
Zhang S; Lai Y; Pan J; Saeed M; Li S; Zhou H; Jiang X; Gao J; Zhu Y; Yu H; Zhang W; Xu Z
Adv Mater; 2024 Jun; 36(23):e2314132. PubMed ID: 38353332
[TBL] [Abstract][Full Text] [Related]
15. The evolving concepts of cancer stem cells in head and neck squamous cell carcinoma.
Shah A; Patel S; Pathak J; Swain N; Kumar S
ScientificWorldJournal; 2014; 2014():842491. PubMed ID: 24574924
[TBL] [Abstract][Full Text] [Related]
16. Intron 1-Mediated Regulation of
Jameson NM; Ma J; Benitez J; Izurieta A; Han JY; Mendez R; Parisian A; Furnari F
Mol Cancer Res; 2019 Nov; 17(11):2208-2220. PubMed ID: 31444232
[TBL] [Abstract][Full Text] [Related]
17. NF-κB-Dependent Lymphoid Enhancer Co-option Promotes Renal Carcinoma Metastasis.
Rodrigues P; Patel SA; Harewood L; Olan I; Vojtasova E; Syafruddin SE; Zaini MN; Richardson EK; Burge J; Warren AY; Stewart GD; Saeb-Parsy K; Samarajiwa SA; Vanharanta S
Cancer Discov; 2018 Jul; 8(7):850-865. PubMed ID: 29875134
[TBL] [Abstract][Full Text] [Related]
18. Super-enhancer trapping by the nuclear pore via intrinsically disordered regions of proteins in squamous cell carcinoma cells.
Hazawa M; Ikliptikawati DK; Iwashima Y; Lin DC; Jiang Y; Qiu Y; Makiyama K; Matsumoto K; Kobayashi A; Nishide G; Keesiang L; Yoshino H; Minamoto T; Suzuki T; Kobayashi I; Meguro-Horike M; Jiang YY; Nishiuchi T; Konno H; Koeffler HP; Hosomichi K; Tajima A; Horike SI; Wong RW
Cell Chem Biol; 2024 Apr; 31(4):792-804.e7. PubMed ID: 37924814
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
Bacabac M; Xu W
Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
[TBL] [Abstract][Full Text] [Related]
20. Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder cancer progression through the WNT pathway.
Tan M; Pan Q; Gong H; Zhai X; Wan Z; Ge M; Gu J; Zhang D; Chen X; Xu D
Pharmacol Res; 2023 Nov; 197():106940. PubMed ID: 37758102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
